David Glenn Harrison

Vanderbilt University

Public scientific profile · Unclaimed

Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.

Top expertise

  • Cardiovascular Syncope and Autonomic Disorders

    Strong evidence · 2 supporting papers · latest 2026

  • Monoclonal and Polyclonal Antibodies Research

    Strong evidence · 2 supporting papers · latest 2025

  • Bone health and osteoporosis research

    Strong evidence · 2 supporting papers · latest 2026

  • vaccines and immunoinformatics approaches

    Strong evidence · 1 supporting paper · latest 2025

  • Immunotherapy and Immune Responses

    Strong evidence · 1 supporting paper · latest 2025

  • Blood Pressure and Hypertension Studies

    Strong evidence · 1 supporting paper · latest 2025

  • Bone Metabolism and Diseases

    Solid evidence · 3 supporting papers · latest 2026

  • Cancer Immunotherapy and Biomarkers

    Solid evidence · 1 supporting paper · latest 2026

Publications (15)

  • Machine learning application to predict binding affinity between peptide containing non-canonical amino acids and HLA-A0201

    2025DOIPMID 40577315

  • Monocyte Oxidative Stress Underlies Persistent Immune Activation in Long COVID Postural Orthostatic Tachycardia Syndrome

    2026DOIPMID 42245008

  • Hypertension Editors’ View of the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

    2025DOIPMID 40961216

  • Abstract FR493: Immune Activation Driven by Circulating T Cell-Monocyte Complexes with Elevated IsoLG-Adducted Proteins in Postural Orthostatic Tachycardia Syndrome: Implications for New Antigen Formation and Persistent Inflammation

    2025DOI

  • Programmed cell death ligand 1 (PD-L1) inhibition in tumor naïve mice is bone-sparing throughout the lifespan

    2026DOIPMID 42424413

  • Hypertension worsens bone loss and weakens bone in aged ovariectomized mice

    2026DOIPMID 42427915

  • Hypertension promotes bone loss and fragility by favoring bone resorption in mouse models

    2025DOIPMID 40828611

  • Abstract TAC238: Predicting Peptide-Human Leukocyte Antigen and Isolevuglandin Immunogenicity in Hypertension Using Structure-based Deep Learning

    2025DOI

  • Abstract TAC207: Hypertension-Driven Bone Loss and Immune Activation in an Aging Mice: Pharmacologic Prevention

    2025DOI

  • The adventitia, vascular inflammation, and the intersection of hypertension and vascular disease

    2026DOIPMID 42566987

  • Research Letters and Editorials in Hypertension

    2025DOIPMID 40532019

  • Brush border intermicrovillar adhesion limits bacteria attachment to the small intestine brush border

    2025DOIPMID 41502946

  • Effects of Oxygen on Perioperative Vascular Function: A Randomized Clinical Trial

    2025DOIPMID 40673571

  • Abstract FR560: Similarities of T cells contributing to Experimental Hypertension and Psoriasis

    2025DOI

  • Abstract TAC178: T cells activated by IsoLG-adducts display variable organ distribution depending on sex in Hypertension

    2025DOI

Organizations in sourced records

Affiliation evidence only — not confirmed current employment.

  • Vanderbilt University

Source: OpenAlex · retrieved 2026-09-29

Are you David Glenn Harrison? Sign in to claim this profile